Bioformulation like antibodies, Vaccines and nucleic acid products are the major drug consumed by the patients. Their interaction with the body, their stability, and the shelf life and their delivery system must analysed before formulating the drug. The Pharmaceutical industry has evolved to use genetic engineering to produce 3rd generation drugs like long lasting and fast acting insulin, erythropoietin, the GM microorganism were used to produce the bioproduct of interest. There is a need for the development of new drugs for emerging diseases. All your ideas and research are welcomed at this conference, Join us in Paris on February 17-18.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
